The Wearable–Clinic Gap: Plenty of Data, Little Sharing
Wearable data sharing with doctors refers to the process by which health metrics from consumer devices, such as smartwatches and continuous glucose monitors, are securely transferred into clinical workflows so clinicians can interpret and act on them as part of medical care rather than leaving them as isolated wellness numbers. Recent survey data shows how far reality is from that ideal. In a study of 17,395 adults across 2020, 2022, and 2024, wearable use climbed from 30.2% to 41.1%, and about half of users reported daily use. Yet willingness to share data with clinicians, while still high, slipped from 81.3% to 73.4%, and real-world sharing never crossed 20%. The study’s authors warned of “opposing trends in device adoption and the level of engagement required for wearable data to meaningfully inform health care,” highlighting a widening disconnect between self-tracking and clinical decision-making.
Apple, Samsung, and the Promise of Glucose AI
While smartwatches still lack reliable, noninvasive glucose sensing, major brands are racing to build ecosystems around continuous glucose monitoring adoption. Apple and Samsung are exploring ways to plug phone-and-watch platforms into CGMs, importing glucose data and using health AI to explain what those curves mean alongside sleep, stress, exercise, and heart metrics. The aim is clear: move from raw numbers to personalized, real-time coaching. According to eWeek, Apple’s stack of Apple Watch, iPhone, Health app, HealthKit, and Apple Intelligence, and Samsung’s Galaxy Watch, Galaxy Ring, Samsung Health, and Galaxy AI give both companies many of the pieces needed to compete on this AI interpretation layer. Partnerships like Oura’s integration of Dexcom’s Stelo CGM, which combines glucose readings with sleep and activity data and AI summaries, show how CGM clinical use and wellness use are beginning to blur inside consumer experiences.
Why Patients Rarely Share Wearable Metrics With Doctors
If health platforms are eager for data, why is wearable data sharing with doctors so low? First, workflows are messy: few clinics have seamless ways to ingest step counts, heart rate trends, or glucose streams from consumer apps into electronic records without extra clicks. Second, clinicians worry about liability, since glucose and other metrics can drive high-stakes decisions; without clear guidelines, they may avoid acting on unverified consumer dashboards. Third, patients face behavioral friction: confusing app settings, privacy concerns, and uncertainty about whether their doctor wants the information. The Yale study shows that despite more people wearing devices daily, the percentage who transfer data to clinicians remains stuck below one in five. That gap suggests awareness and intent are not enough; both sides need clear expectations about which metrics matter, when to share them, and how they will influence care.
Health AI Integration Barriers: From Sensors to Clinical Action
For glucose in particular, health AI integration barriers sit at the intersection of hardware limits and regulation. Regulators have warned consumers not to rely on smartwatches or rings that claim to measure blood sugar without skin penetration, due to the risk of inaccurate readings. That pushes Apple, Samsung, and others toward CGM clinical use, where sensors already provide reliable data but must be interpreted carefully. Glucose is not a step count; it can trigger medication changes, diet shifts, and safety decisions. Any AI that suggests actions risks crossing from wellness coaching into medical advice in the eyes of regulators. This makes it hard to move from friendly nudges to clinically endorsed guidance. Until AI systems can prove accuracy, explainability, and safe escalation paths to human clinicians, most providers will keep wearable data at arm’s length, especially for sensitive metabolic metrics.
The Next Frontier: Making Wearable Glucose Data Clinically Useful
The real opportunity is not more sensors but better links between continuous glucose monitoring adoption and everyday clinical practice. The emerging model, seen in Dexcom–Oura’s collaboration, separates sensing from interpretation: the CGM captures precise glucose signals, while a wearable platform adds AI-driven explanations across sleep, activity, stress, and recovery. For healthcare systems, that concept needs a clinical version. That means standardized data formats, filters that surface only medically relevant patterns, and summaries that fit into a 15-minute visit. It also means clear consent flows and guardrails so wellness-style advice does not pretend to be treatment. If developers can close the gap between data collection and clinical actionability, doctors could receive concise, validated glucose trend reports rather than overwhelming raw streams. Until then, millions of people will continue to track detailed health metrics that their clinicians rarely see—or feel able to use.
